153 related articles for article (PubMed ID: 8554307)
1. Clinical pharmacokinetics of oral cephalosporins.
Stoeckel K; Hayton WL; Edwards DJ
Antibiot Chemother (1971); 1995; 47():34-71. PubMed ID: 8554307
[No Abstract] [Full Text] [Related]
2. Comparative pharmacokinetics of the new oral cephalosporins.
Lode H; Fassbender M; Schaberg T; Borner K; Koeppe P
Drugs; 1994; 47 Suppl 3():10-9; discussion 19-20. PubMed ID: 7518762
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of valproic acid.
Gugler R; von Unruh GE
Clin Pharmacokinet; 1980; 5(1):67-83. PubMed ID: 6767575
[No Abstract] [Full Text] [Related]
4. A review of the clinical pharmacokinetics of amiodarone.
Paton DM; Webster DR; Neutze JM
Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):41-9. PubMed ID: 6371407
[No Abstract] [Full Text] [Related]
5. [Oral cephalosporins. Relationship between structure, pharmacokinetics and action].
Christ W; Stein H
Med Monatsschr Pharm; 2002 Apr; 25(4):112-24; quiz 125. PubMed ID: 11980324
[No Abstract] [Full Text] [Related]
6. Systematics of beta-lactams: chemical properties and structure activity relationship of oral cephalosporins.
Kees F; Grobecker H
Antibiot Chemother (1971); 1995; 47():1-7. PubMed ID: 8554302
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics and tissue penetration of cefprozil.
Nye K; O'Neill P; Andrews JM; Wise R
J Antimicrob Chemother; 1990 May; 25(5):831-5. PubMed ID: 2373665
[TBL] [Abstract][Full Text] [Related]
8. Studies on cephalosporin antibiotics. I. Synthesis, antibacterial activity and oral absorption of new 3-(O-substituted)-7 beta-[D-alpha-amino-alpha-(4-hydroxyphenyl)acetamido]cephalosporins.
Yokoo C; Goi M; Onodera A; Murata M; Nagate T; Watanabe Y; Sota K
J Antibiot (Tokyo); 1988 Feb; 41(2):170-80. PubMed ID: 3356605
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of ceftibuten in humans.
Barr WH; Lin CC; Radwanski E; Lim J; Symchowicz S; Affrime M
Diagn Microbiol Infect Dis; 1991; 14(1):93-100. PubMed ID: 2013216
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
Kim YC; Kim IB; Noh CK; Quach HP; Yoon IS; Chow ECY; Kim M; Jin HE; Cho KH; Chung SJ; Pang KS; Maeng HJ
J Pharm Sci; 2014 Nov; 103(11):3793-3805. PubMed ID: 25266751
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of systemic antifungal drugs.
Daneshmend TK; Warnock DW
Clin Pharmacokinet; 1983; 8(1):17-42. PubMed ID: 6301738
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of new oral cephalosporins, including a new carbacephem.
Fassbender M; Lode H; Schaberg T; Borner K; Koeppe P
Clin Infect Dis; 1993 May; 16(5):646-53. PubMed ID: 8507756
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the pharmacokinetics of BMY-28100 (I)].
Nakanomyo H; Ishikawa K; Esumi Y; Takaichi M; Jin Y; Gunji S; Ishikawa H; Sonobe J
Jpn J Antibiot; 1990 Jul; 43(7):1310-24. PubMed ID: 2232159
[TBL] [Abstract][Full Text] [Related]
15. Orally absorbable D-forphenicinol-cephalosporins.
Koyama Y; Huang SP; Ikeda D; Hamada M; Kondo S; Takeuchi T
J Antibiot (Tokyo); 1989 Jun; 42(6):993-9. PubMed ID: 2737957
[TBL] [Abstract][Full Text] [Related]
16. Orally active 2-(alkyloxycarbonyl)-2-alkylideneethyl esters of cephalosporins.
Hubschwerlen C; Charnas R; Angehrn P; Furlenmeier A; Graser T; Montavon M
J Antibiot (Tokyo); 1992 Aug; 45(8):1358-64. PubMed ID: 1399857
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy: The newer cephalosporins.
Moellering RC; Swartz MN
N Engl J Med; 1976 Jan; 294(1):24-8. PubMed ID: 1105179
[No Abstract] [Full Text] [Related]
18. Paediatric pharmacological principles: an update. Part 2. Pharmacokinetics: absorption and distribution.
Kanneh A
Paediatr Nurs; 2002 Nov; 14(9):39-43. PubMed ID: 12510334
[No Abstract] [Full Text] [Related]
19. Bioavailability and pharmacokinetics of cefoxitin sodium.
Schrogie JJ; Davies RO; Yeh KC; Rogers D; Holmes GI; Skeggs H; Martin CM
J Antimicrob Chemother; 1978 Jul; 4(B):69-78. PubMed ID: 99418
[No Abstract] [Full Text] [Related]
20. Clinical pharmacokinetics of cyclophosphamide.
Grochow LB; Colvin M
Clin Pharmacokinet; 1979; 4(5):380-94. PubMed ID: 389529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
